Weight Loss Win for Weekly Injections of Novel Amylin Agent in Early Trial | MedPage Today

The investigational long-acting amylin analogue cagrilintide (AM833) helped people with overweight or obesity, but no diabetes, shed pounds in a ...

from Google Alert - How to lose weight https://ift.tt/3qNF4jJ